Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Fennec Pharmaceuticals (FENC) FCF Margin (2020 - 2025)

Historic FCF Margin for Fennec Pharmaceuticals (FENC) over the last 6 years, with Q3 2025 value amounting to 11.98%.

  • Fennec Pharmaceuticals' FCF Margin rose 436100.0% to 11.98% in Q3 2025 from the same period last year, while for Sep 2025 it was 20.59%, marking a year-over-year decrease of 648700.0%. This contributed to the annual value of 56.75% for FY2024, which is 1374200.0% up from last year.
  • Latest data reveals that Fennec Pharmaceuticals reported FCF Margin of 11.98% as of Q3 2025, which was up 436100.0% from 38.19% recorded in Q2 2025.
  • Over the past 5 years, Fennec Pharmaceuticals' FCF Margin peaked at 49177.78% during Q2 2021, and registered a low of 332.56% during Q1 2023.
  • Moreover, its 5-year median value for FCF Margin was 25.12% (2024), whereas its average is 4095.87%.
  • In the last 5 years, Fennec Pharmaceuticals' FCF Margin plummeted by -432304100bps in 2022 and then surged by 4795700bps in 2024.
  • Fennec Pharmaceuticals' FCF Margin (Quarter) stood at 5378.18% in 2021, then plummeted by -86bps to 744.2% in 2022, then plummeted by -107bps to 49.92% in 2023, then skyrocketed by 63bps to 18.6% in 2024, then soared by 164bps to 11.98% in 2025.
  • Its last three reported values are 11.98% in Q3 2025, 38.19% for Q2 2025, and 49.34% during Q1 2025.